Market Tracker

11/21 6:05pm ET

Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

3.17
Data as of Nov 21
 +0.018 / +0.57%
Today’s Change
1.54
Today|||52-Week Range
5.70
+17.33%
Year-to-Date
No recent news for Brainstorm Cell Therapuetics Inc.

Today’s Trading

Previous close3.15
Today’s open3.15
Day’s range3.06 - 3.19
Volume20,916
Average volume (3 months)77,176
Market cap$48.4M
Dividend yield--
Data as of 3:56pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book13.59

Competitors

 Today’s
change
Today’s
% change
CASICASI Pharmaceuticals...+0.13+8.44%
IMUCImmunoCellular Thera...-0.01-2.11%
PBMDPrima BioMed Ltd-0.03-2.87%
ABACAoxin Tianli Group I...-0.01-0.44%
Data as of 3:59pm ET, 11/21/2014

Financials

Last reporting dateNovember 13, 2014
EPS forecast (this quarter)-$2.40
Annual revenue (last year)$0.00
Annual profit (last year)-$4.9M
Net profit margin--

Profile

Sector
Electronic Technology
Industry
Computer Peripherals
Chief Executive Officer
Anthony S. Fiorino
President
Chaim Lebovits
Corporate headquarters
New York, New York

Forecasts